Intravenous administration of adenoviruses targeting transforming growth factor beta signaling inhibits established bone metastases in 4T1 mouse mammary tumor model in an immunocompetent syngeneic host
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Intravenous administration of adenoviruses targeting transforming growth factor beta signaling inhibits established bone metastases in 4T1 mouse mammary tumor model in an immunocompetent syngeneic host
Authors
Keywords
-
Journal
CANCER GENE THERAPY
Volume 19, Issue 9, Pages 630-636
Publisher
Springer Nature
Online
2012-06-29
DOI
10.1038/cgt.2012.41
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The role of antiresorptive therapies in improving patient care in early and metastatic breast cancer
- (2011) Dulcinea Candelaria-Quintana et al. BREAST CANCER RESEARCH AND TREATMENT
- TGFβ-dependent induction of interleukin-11 and interleukin-8 involves SMAD and p38 MAPK pathways in breast tumor models with varied bone metastases potential
- (2011) Janhavi Gupta et al. CANCER BIOLOGY & THERAPY
- Adenoviral Vector Immunity: Its Implications and Circumvention Strategies
- (2011) Yadvinder S. Ahi et al. CURRENT GENE THERAPY
- Systemic Delivery of a Novel Liver-Detargeted Oncolytic Adenovirus Causes Reduced Liver Toxicity but Maintains the Antitumor Response in a Breast Cancer Bone Metastasis Model
- (2011) Zhenwei Zhang et al. HUMAN GENE THERAPY
- Oncolytic Adenovirus Expressing Soluble TGFβ Receptor II-Fc-mediated Inhibition of Established Bone Metastases: A Safe and Effective Systemic Therapeutic Approach for Breast Cancer
- (2011) Zebin Hu et al. MOLECULAR THERAPY
- TGF-β in cancer and bone: Implications for treatment of bone metastases
- (2010) Patricia Juárez et al. BONE
- Biology of breast cancer bone metastasis
- (2010) Mojtaba Akhtari et al. CANCER BIOLOGY & THERAPY
- Oncolytic (replication-competent) adenoviruses as anticancer agents
- (2010) Karoly Toth et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Systemic Delivery of an Oncolytic Adenovirus Expressing Soluble Transforming Growth Factor-β Receptor II–Fc Fusion Protein Can Inhibit Breast Cancer Bone Metastasis in a Mouse Model
- (2010) Zebin Hu et al. HUMAN GENE THERAPY
- Mechanisms of Endocytosis
- (2009) Gary J. Doherty et al. Annual Review of Biochemistry
- A modified hTERT promoter-directed oncolytic adenovirus replication with concurrent inhibition of TGFβ signaling for breast cancer therapy
- (2009) Z Hu et al. CANCER GENE THERAPY
- Targeting the transforming growth factor-β signaling pathway in human cancer
- (2009) Nagathihalli S Nagaraj et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- A Phase I Study of Telomerase-specific Replication Competent Oncolytic Adenovirus (Telomelysin) for Various Solid Tumors
- (2009) John Nemunaitis et al. MOLECULAR THERAPY
- Imaging transforming growth factor-β signaling dynamics and therapeutic response in breast cancer bone metastasis
- (2009) Manav Korpal et al. NATURE MEDICINE
- Transforming Growth Factor Subverts the Immune System into Directly Promoting Tumor Growth through Interleukin-17
- (2008) J.-S. Nam et al. CANCER RESEARCH
- Adenovirus Serotype 5 Hexon Mediates Liver Gene Transfer
- (2008) Simon N. Waddington et al. CELL
- Roles of TGFβ in metastasis
- (2008) David Padua et al. CELL RESEARCH
- Immunosuppression Enhances Oncolytic Adenovirus Replication and Antitumor Efficacy in the Syrian Hamster Model
- (2008) Maria A Thomas et al. MOLECULAR THERAPY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now